- Home
- DCOM vs ELVN Comparison
DCOM vs ELVN Comparison
Compare DCOM & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOM
- ELVN
- Stock Information
- Founded
- DCOM 1864
- ELVN 2016
- Country
- DCOM United States
- ELVN United States
- Employees
- DCOM N/A
- ELVN N/A
- Industry
- DCOM Major Banks
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- DCOM Finance
- ELVN Health Care
- Exchange
- DCOM Nasdaq
- ELVN Nasdaq
- Market Cap
- DCOM 1.2B
- ELVN 1.2B
- IPO Year
- DCOM 1996
- ELVN 2020
- Fundamental
- Price
- DCOM $28.69
- ELVN $22.63
- Analyst Decision
- DCOM Buy
- ELVN Strong Buy
- Analyst Count
- DCOM 4
- ELVN 5
- Target Price
- DCOM $33.88
- ELVN $41.20
- AVG Volume (30 Days)
- DCOM 284.9K
- ELVN 721.5K
- Earning Date
- DCOM 07-22-2025
- ELVN 08-12-2025
- Dividend Yield
- DCOM 3.47%
- ELVN N/A
- EPS Growth
- DCOM N/A
- ELVN N/A
- EPS
- DCOM 0.62
- ELVN N/A
- Revenue
- DCOM $295,419,000.00
- ELVN N/A
- Revenue This Year
- DCOM $46.03
- ELVN N/A
- Revenue Next Year
- DCOM $16.60
- ELVN N/A
- P/E Ratio
- DCOM $46.08
- ELVN N/A
- Revenue Growth
- DCOM N/A
- ELVN N/A
- 52 Week Low
- DCOM $20.78
- ELVN $13.30
- 52 Week High
- DCOM $37.60
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- DCOM 61.16
- ELVN 60.45
- Support Level
- DCOM $27.93
- ELVN $19.38
- Resistance Level
- DCOM $29.26
- ELVN $21.34
- Average True Range (ATR)
- DCOM 0.78
- ELVN 1.27
- MACD
- DCOM 0.18
- ELVN 0.11
- Stochastic Oscillator
- DCOM 83.53
- ELVN 88.47
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.